Metabolomics is a dynamically evolving field, with a major application in identifying
biomarkers for drug development and personalized medicine. Numerous metabolomic …

Metabolomics is the untargeted measurement of the metabolome, which is composed of the
complement of small molecules detected in a biological sample. As such, metabolomic …

The gap of the post-genomic era is increasingly being filled by the metabolomics approach,
comprising a technology for analyzing small molecule endogenous metabolites (≤ 1500 …

Over the last decades there has been a change in biomedical research with the search for
single genes, transcripts, proteins, or metabolites being substituted by the coverage of the …

Despite the significant advantages of metabolomic biomarkers, no diagnostic tests based on
metabolomics have been introduced to clinical use. There are many reasons for this …

The current developments in metabolomics and metabolic profiling technologies have led to
the discovery of several new metabolic biomarkers. Finding metabolites present in …

Metabolomics is only truly unbiased if the whole metabolome is captured. Current
metabolomics technologies capture only a part of the metabolome and therefore produce …

Metabolomics is increasingly being applied towards the identification of biomarkers for
disease diagnosis, prognosis and risk prediction. Unfortunately among the many published …

Today, the technology of 'targeted'based metabolomics is pivotal in the clinical analysis
workflow as it provides information of metabolic phenotyping (metabotypes) by enhancing …

Unmet clinical diagnostic needs exist for many complex diseases, which it is hoped will be
solved by the discovery of metabolomics biomarkers. However, as yet, no diagnostic tests …